Select Medical faces a challenging outlook characterized by significant revenue volatility and structural margin compression, as evidenced by gross margins struggling to sustain levels above 13%.
Price trend, volume and key moving averages
Trailing total returns as of 11/8/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC).
Check whether operating performance supports the current valuation.
Recent results and news deserve attention only when they alter the forward view.
| Quarter | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|
Q2 2026Latest Apr 30, 2026 | $0.36-16.3% vs $0.43 | $1.4B+0.7% vs $1.4B |
Q1 2026 Feb 19, 2026 | $0.16-30.4% vs $0.23 | $1.4B+2.4% vs $1.4B |
Q4 2025 Oct 30, 2025 | $0.23+27.8% vs $0.18 | $1.4B+2.5% vs $1.3B |
Q3 2025 Jul 31, 2025 | $0.32+14.3% vs $0.28 | $1.3B-0.3% vs $1.3B |
Benchmark SEM against direct peers instead of judging its metrics in isolation.
Key metrics vs top competitors for Select Medical Holdings Corporation (SEM)
| Company | Price | Market Cap | P/E Ratio | Rev Growth (1Y) | Net Margin | ROE | Div Yield |
|---|---|---|---|---|---|---|---|
| $16.51 | $2.05B | 13.99 | 5.12% | 2.68% | 7.25% | 1.54% | |
| $181.08 | $10.55B | 31.01 | 18.72% | 7.03% | 16.61% | 0.14% | |
| $37.00 | $3.44B | -3.04 | 5.04% | -33.44% | -46.01% | — | |
| $195.50 | $11.83B | 8.46 | 9.71% | 7.96% | 19.27% | 0.41% | |
| $23.20 | $3.03B | -38.03 | 6.24% | -2.63% | -2.59% | — | |
| $494.99 | $107.17B | 17.44 | 7.08% | 8.61% | — | 0.59% |
Select Medical Holdings Corporation (SEM) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
Verify the primary filings, follow material updates, and answer the remaining questions.
Select Medical Holdings Corporation (SEM) SEC filings — annual & quarterly reports (10-K, 10-Q)
Jul 1, 2026·SEC
Jun 26, 2026·SEC
Jun 22, 2026·SEC
Get notified when SEM posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
Select Medical Holdings Corporation (SEM) stock FAQ — growth, dividends, profitability & financials explained
Select Medical Holdings Corporation (SEM) reported $5.52B in revenue over the trailing twelve months. Revenue was $5.45B in fiscal year 2025. That is 193% more than the $1.86B of fiscal year 2005.
Select Medical Holdings Corporation (SEM) grew revenue by 5.1% in fiscal year 2025, compared with the prior fiscal year.
Yes. Select Medical Holdings Corporation (SEM) earned $133.5M in net income over the trailing twelve months (a 2.4% net margin).
Yes. Select Medical Holdings Corporation (SEM) pays a dividend that yields 1.54% at the current price, a moderate yield.
Select Medical Holdings Corporation (SEM) had a return on equity (ROE) of 7.3% in fiscal year 2025. That is below the market's typical 10-15%.
Select Medical Holdings Corporation (SEM) generated $117.2M in free cash flow over the trailing twelve months.
